TGFB1 and neoplasm: Paradoxically, TGF-β signaling can exacerbate malignant phenotypes at later stages of tumorigenesis, by inducing epithelial-mesenchymal transition (EMT), tumor angiogenesis, and anti-immune reactions [4, 9–11].